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Abstract
Background: Non-tuberculous mycobacteria recovered from respiratory tract specimens are emerging confounder
organisms for the laboratory diagnosis of tuberculosis worldwide. There is an urgent need for new techniques to rapidly
identify mycobacteria isolated in clinical practice. Matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-
TOF MS) has previously been proven to effectively identify mycobacteria grown in high-concentration inocula from
collections. However, a thorough evaluation of its use in routine laboratory practice has not been performed.
Methodology: We set up an original protocol for the MALDI-TOF MS identification of heat-inactivated mycobacteria after
dissociation in Tween-20, mechanical breaking of the cell wall and protein extraction with formic acid and acetonitrile. By
applying this protocol to as few as 10
5 colony-forming units of reference isolates of Mycobacterium tuberculosis,
Mycobacterium avium, and 20 other Mycobacterium species, we obtained species-specific mass spectra for the creation of a
local database. Using this database, our protocol enabled the identification by MALDI-TOF MS of 87 M. tuberculosis,2 5M.
avium and 12 non-tuberculosis clinical isolates with identification scores $2 within 2.5 hours.
Conclusions: Our data indicate that MALDI-TOF MS can be used as a first-line method for the routine identification of heat-
inactivated mycobacteria. MALDI-TOF MS is an attractive method for implementation in clinical microbiology laboratories in
both developed and developing countries.
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Introduction
Pulmonary tuberculosis is a deadly, contagious infection caused
by mycobacteria belonging to the Mycobacterium tuberculosis
complex (MTC) [1]. Tuberculosis remains in the top 10 health
priorities in many developing countries, and with more than 1.3
million new cases yearly [2] and the emergence and rapid spread
of multidrug-resistant and extensively drug-resistant M. tuberculosis
strains in such countries, the rapid laboratory diagnosis of
tuberculosis is essential. However, this task has been complicated
by the emergence of non-tuberculous mycobacteria present in
respiratory tract specimens from patients suspected of pulmonary
tuberculosis, even in countries with a high incidence and burden
of pulmonary tuberculosis [3]. For example, a recent study
showed that 52.5% of non-tuberculous isolates in Taiwan were
from respiratory tract specimens [4]. Indeed, the actinobacterial
genus Mycobacterium comprises more than 120 species including
both obligate human pathogens, such as the leprosy agent
Mycobacterium leprae [5], and the MTC members and opportunistic
pathogens, such as the Mycobacterium avium complex and the
Mycobacterium abscessus group mycobacteria and harmless environ-
mental organisms [6].
The identification of mycobacteria has long been based on
conventional phenotypic methods requiring extensive incubation
times and delaying the final diagnosis far beyond medical
recommendations [3]. In some developing countries, these methods
have been successfully replaced by the direct microscopic detection
of cords specific for M. tuberculosis after a 5–10-day incubation of the
specimen in either agar or miniaturized liquid medium [7,8].
However, thesetechniques stillrequire some degree ofexpertise and
rely on microscopic examination, an operator-dependent method
that is prone to errors. While some other techniques for the
phenotypic analysis of mycobacteria, such as the high-pressure
liquid chromatography of cell wall mycolic acids, proved efficient at
identification, they have not been implemented as a routine
technique in clinical microbiology laboratories [9,10]. Molecular
methods including PCR-based hybridization and sequencing
methods [11,12] are now routinely used for the identification of
mycobacteria in laboratories in developed countries. Recently,
confined real-time PCR has been shown to be effective for the rapid
detection of tuberculosis, including rifampin-resistant tuberculosis,
in respiratory tract specimens [13,14]. These molecular techniques
still require specific technical expertise and technically demanding,
expensive equipment [15–17].
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assisted laser desorption ionization time-of-flight mass spectrom-
etry (MALDI-TOF MS) could also identify mycobacteria [18–21].
Indeed, this technique has emerged over the last few years as a
revolutionary technique for the routine identification of bacterial
isolates [22–32]. MALDI-TOF MS has been shown to yield
accurate results within hours at a lower price than any other
method routinely used in clinical microbiology laboratories [32].
However, the studies supporting this method analyzed high-
concentration inocula [18–21]. In a few studies, mycobacteria
were analyzed without previous inactivation [21,33], which does
not comply with current standards for the manipulation of harmful
organisms.
We therefore aimed to further explore various inactivation
protocols and solvents that one might consider for mycobacteria
with the perspective to decrease the inoculum required for the
accurate MALDI-TOF MS identification of mycobacteria, thus
speeding the diagnosis of tuberculosis and other non-tuberculosis,
mycobacterial infections.
Methods
Mycobacterium strains
As a first step, we used 11 strains of mycobacteria representative
of 7 M. tuberculosis complex species, 12 strains of mycobacteria
representative of 11 M. avium complex species and 20 additional
mycobacteria strains representative of 16 additional non-tubercu-
lous species grown from our collection to set up a reference
database (Table 1). In a second step, all the mycobacteria isolated
from February 2010 to May 2011 from patients in the
Mycobacteria Reference Laboratory, Institut Hospitalier Univer-
sitaire POLMIT, Marseilles, France were prospectively analyzed
by MALDI-TOF MS. The isolates were cultured in MGIT tubes
(Becton Dickinson, Pont-De-Claix, France) or on a home-made
5% sheep blood-agar (BioMe ´rieux, La Balme-les-Grottes, France)
for 2–45 days at 32uCo r3 7 uC as previously described [34,35].
Gram staining was used to ensure the absence of any contaminant
organisms in the culture, and standard identification of mycobac-
teria was performed by observing acid-fast organisms after Ziehl-
Neelsen staining, rpoB sequencing for non-tuberculosis mycobac-
teria [36] and exact tandem repeat D sequencing (ETR-D) for
MTC [12]. We tested two protocols for the inactivation of
mycobacteria before the MALDI-TOF MS by incubating 1 mL of
the mycobacterial suspension obtained by suspending colonies
from solid medium or 3 mL of mycobacteria suspension of liquid
medium either in a water bath at 95uC for one hour (Table 2,
protocol A) [37] or in 70% ethanol for 10 minutes (Table 2,
protocol B) [19]. The effectiveness of each inactivation protocol
was tested in triplicate by inoculating 50 ml inactivated M.
tuberculosis H37Rv, M. bovis BCG and M. fortuitum suspensions in
MGIT tubes incubated in parallel at 37uC. The absence of any
visible growth after incubation for 45 days was taken as an
evidence for the effective inactivation of the mycobacteria.
MALDI-TOF MS protocol for mycobacteria
Several protocols were tested before finalizing the protocol for
the preparation of inactivated mycobacteria. Because some
mycobacteria, including the MTC mycobacteria, are known to
form cords which may hamper the MALDI-TOF MS analysis, we
tested several compounds for their ability to solubilize such
aggregates. We tested the incubation of mycobacteria in a
detergent solution of 0.5% Tween-20 (Table 2, protocol 1) or b-
mercaptoethanol, a chemical known to reduce disulfide bonds in
proteins [38] (Table 2, protocol 2). We also tested the effects of
using acetone (Table 2, protocol 3) or distilled water as a washing
solution; absolute ethanol for protein precipitation (Table 2,
protocol 4); and 0.1 M NaOH (Table 2, protocol 5), 10% v/v
trifluoroacetic acid (TFA) (Table 2, protocol 6), 0.1 M HCl
(Table 2, protocol 7) or 70% formic acid for protein elution
(Table 2, protocol 8). Based on the results of these preliminary
tests, protocol 8 was used for the final experiments. For each
parameter, we compared the results obtained with M. tuberculosis
H37Rv, M. bovis BCG and Mycobacterium fortuitum with the
Table 1. Reference mycobacteria strains used to create a
MALDI-TOF MS database for the identification of
mycobacteria.
Mycobacterium tuberculosis complex
M. tuberculosis CIP 103471; H37Rv; CH6431
M. africanum CIP 105147
M. bovis CIP 671203; CIP 108541
T; CIP105050
M. bovis BCG Tokyo ATCC 35737
M. caprae CIP105776
M. microti CRBIP7.40
M. canettii CIP 140010059
T
M. pinnipedii ATCC-BAA-688
Mycobacterium avium complex
M. avium subsp. hominissuis IWGMT49
M. avium subsp. avium CIP104244
T
M. avium subsp. paratuberculosis CIP103963
M. avium subsp. silvaticum CIP103317
M. colombiense FI 04062
M. chimaera CIP 107892
T; DSM 446232
M. marseillense CIP 109828
T
M. timonense CIP 109830
T
M. bouchedurhonense CIP 109827
T
M. intracellulare CIP104243
T
M. indicus pranii* DSM 45239*
M. arosiense DSM 45069
T
Other Mycobacteria
M. smegmatis CIP104444
T, ATCC 700084
M. abscessus subsp. abscessus DSM 43567, DSM 43435, DSM 43439,
CIP104536
T
M. abscessus subsp. bolletii CIP108541
T, CIP108297
M. aurum CIP104465
T
M. chelonae CIP104535
T
M. fortuitum subsp. fortuitum CIP104524
T
M. gordonae CIP104529
T
M. kansasii CIP104589
T
M. marinum CIP104528
T
M. phlei CIP105389
T
M. xenopi CIP104035
T
M. immunogenum CIP 106684
T
M. lentiflavum CIP105465
M. simiae CIP104531
T
*M. indicus pranii is not a validated species.
doi:10.1371/journal.pone.0024720.t001
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to 3), number of peaks in the 5,000–20,000 m/z range, and the
intensity of the peaks, as determined by the Flex Analysis 3.0
software (Bruker Daltonics). Each test was done ten times.
Sensitivity of MALDI-TOF MS detection
In order to determine the sensitivity of our final protocol, serial
10-fold dilutions from 10
8 to 10
3 mycobacteria/mL were prepared
for M. tuberculosis H37Rv, M. bovis BCG and Mycobacterium fortuitum.
For each suspension, the inoculum was calibrated using two
methods. First, by counting the mean number of mycobacteria
observed in five areas on three slides of Ziehl-Neelsen stained
mycobacteria observed at a 1,0006 magnification. Second, by
culturing the dilutions on blood agar plates for 5 weeks and
counting the number of colonies. In order to facilitate this
quantification, ImageJ colony-counting software (http://rsb.info.
nih.gov/ij/) was used. The sensitivity was then calculated by
reporting the colony number with the fold dilutions.
Mycobacterial MALDI-TOF database
To complement the Bruker Daltonics database, we analyzed a
collection of reference strains for mycobacteria using protocol 8, as
presented below. For each reference mycobacterial strain, one
colony was selected from the agar plate for the solid medium, and
approximately 3 ml of mycobacterial suspension was extracted for
the liquid medium and was manipulated as described above. Each
reference strain was analyzed four times using the same protocol.
For each sample, 1.5 mL was deposited on a polished steel MSP 96
target plate (Bruker Daltonics, Bremen, Germany) and 1.5 mLo f
matrix solution (saturated a-cyano-4-hydroxycinnamic acid, 50%
acetonitrile, 2.5% trifluoroacetic acid) was then added. The
samples were air-dried for 5 minutes before being processed in the
mass spectrometer. To validate the analysis of a whole MSP 96
target, Bacterial Test Standard (Escherichia coli DH5alpha protein
extract; Bruker Daltonics ref 255343) was used as a positive
control and non-inoculated matrix solution (alpha-cyano-4-
Hydroxycinnamic acid) was used as a negative control on each
plate. The analyses were performed using the Microflex MALDI-
TOF MS spectrometer (Bruker Daltonics) at 337 nm with the Flex
control software (Bruker Daltonics). Positive ions were extracted
with an accelerating voltage of 20 KV in linear mode. The spectra
were analyzed within an m/z range of 2,000 to 20,000. Four raw
spectra were automatically acquired using the Flexcontrol 3.0
software and then compared with the Bruker Daltonics database
using the MALDI Biotyper 2.0 Bruker Daltonics software. To
validate the analysis using the MALDI Biotyper software, the
identification of the positive control was required to be E. coli with
an identification score $2, and the negative control had to yield a
non-identifying score #1.7.
The profiles of the 11 reference strains for the M. tuberculosis
complex, 12 reference strains for the M. avium complex and 20
reference strains for the other non-tuberculous mycobacteria were
compared and analyzed using the Biotyper 2.0 software, and the
MALDI-TOF MS spectra were entered into a local Mycobacterium
database that was further merged with the 3,438-entry Bruker
Daltonics database (June 2010).
MALDI-TOF MS identification of mycobacteria
All the clinical Mycobacterium isolates prospectively obtained from
the Mycobacteria Reference Laboratory, Institut Hospitalier
Universitaire POLMIT, Marseilles, France from February 2010
to May 2011 were prospectively analyzed using protocol 8, as
presented below. To identify each clinical isolate, the correspond-
ing spectra were then compared with those in the local
Mycobacterium database merged with the Bruker Daltonics database
using the Biotyper software 2.0.
Results
MALDI-TOF MS protocol for mycobacteria
We observed no growth of M. tuberculosis, M. bovis BCG and M.
fortuitum mycobacteria over a 45-day incubation after either heat
inactivation or a 10-minute incubation with 70% ethanol.
However, the incubation of Middlebrook 7H9-grown mycobacte-
ria in ethanol yielded protein profiles of lower quality (Figure 1
part a) than those obtained after heat-inactivation. Therefore, the
1-hour incubation at 95uC was incorporated into our final
protocol. Likewise, because incubating mycobacteria in 0.5%
Tween-20 yielded spectra of better quality than mycobacteria run
in parallel without Tween-20 treatment (Table 3.1; Figure 1 part
b), 0.5% Tween-20 treatment was incorporated into our final
protocol. We found that the suspension of mycobacteria in b-
mercaptoethanol did not improve the quality of spectra (Table 3.2;
Figure 1 part c), so b-mercaptoethanol was not used in our final
protocol. We then tested the use of acetone and distilled water as
washing solutions. No difference was observed between the
spectra; both resulted in adequate identification with almost the
same intensity and score (Table 3.3; Figure 1 part d). Acetone took
longer to manipulate and to dry than distilled water, which was
therefore retained in the final protocol. We observed that protein
precipitation using absolute ethanol (Table 3.4; Figure 1 part e) did
not improve the quality of the spectra when compared with
distilled water alone. We also tested several protein extraction and
elution solvents. No peak was observed in the 5,000–15,000 Kda
range with 0.1 M NaOH (Table 3.5; Figure 1 part f) or 0.1 M HCl
(Table 3.6; Figure 1 part.f), only one peak was observed with 10%
TFA (Table 3.7; Figure 1 part g) and 11 peaks were obtained using
70% HCOOH (Table 3.8; Figure 1 part i). We therefore
incorporated 70% HCOOH combined with 100% acetonitrile
into our final protocol.
Protocol 8 (Table 3.9; Figure 1 part i) was used as the final
protocol. Colonies from each isolate were collected in a screw-cap
Eppendorf tube containing 500 ml of HPLC-grade water and
0.5% Tween-20 and inactivated by heating at 95uC for one hour
[37]. The mycobacterial suspensions were then washed twice with
Table 2. Inactivation protocols and solvents used to treat
mycobacteria for identification by MALDI-TOF MS.
Protocol Inactivation protocol
A9 5 uC/60 minutes
B 70% ethanol/10 minutes
Solvent type and
composition
1 0.5% Tween-20 Mycobacteria aggregate dissociation
25 % b-mercaptoethanol Mycobacteria aggregate dissociation
3 Acetone Washing
4 Absolute ethanol Protein precipitation
5 0.1 M NaOH Protein extraction/elution
6 10% TFA Protein extraction/elution
7 0.1 M HCl Protein extraction/elution
8 70% HCOOH Protein extraction/elution
doi:10.1371/journal.pone.0024720.t002
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10 min. The pellet was vortexed along with 500 mL of HPLC-
grade water and 0.3 g acid-washed glass beads (diameter
#106 mm, Sigma) in a BIO 101 FastPrep instrument (Qbiogene,
Strasbourg, France) at level 6.5 (full speed) for 3 min. The
suspension was centrifuged at 13,0006g for 10 min. The pellet
was then resuspended in 5 to 50 ml 70% HCOOH and 5 to 50 ml
100% acetonitrile, depending on the volume of the pellet. The
suspension was centrifuged at 11,0006g for 1 min and 1.5 mlo f
the supernatant was deposited on a target plate (Bruker Daltonics,
Bremen, Germany) in four replicates. Finally, 1.5 ml matrix
solution (saturated a cyano-4-hydroxycinnamic acid, 50% aceto-
nitrile, 2.5% TFA) was added and allowed to co-crystallize with
the sample pellet at room temperature.
Mycobacterium MALDI-TOF database
Using our optimized protocol, the lower limit of detection of
MALDI-TOF MS was about 10
5 CFU/mL, which corresponds to
10
3 mycobacteria deposited on the MALDI-TOF MS plate. All of
the mycobacteria reference strains tested by mass spectrometry
had a species-specific spectrum profile. Spectrum profiles were
deposited in a spectrum database that is an internal MALDI-TOF
database of La Timone hospital Which combined with the Bruker
database yielded a total of 141 reference spectra comprising of 62
Mycobacterium species (Table S1).
MALDI-TOF identification of mycobacteria
In all cases, the negative control wells yielded either no visible
peaks or faint profiles that were not interpreted by the system, and
Figure 1. MALDI-TOF MS spectra obtained from the M. tuberculosis H37Rv strain using the protocols tested herein. Protocol A was
used throughout; protocol B was used where mentioned (Line 2).
doi:10.1371/journal.pone.0024720.g001
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124 clinical isolates were prospectively analyzed within a 16-
month period by MALDI-TOF MS and all tested mycobacterial
isolates yielded a visible protein profile with an identification score
of 2 to 2.7. Of the clinical isolates, 87 were identified as M.
tuberculosis,1 7a sM. avium subsp. hominisuis,7a sM. intracellulare, one
as M. marsiliense,7M. chelonae,2a sM. abscessus,2a sM. kansasii and
one as M. fortuitum. In all cases, the MALDI-TOF MS
identification agreed with the molecular identification routinely
performed in our laboratory using either ETR-D sequencing for
the identification of MTC species [12] or partial rpoB sequencing
for the other mycobacteria [36].
Discussion
The protein spectra obtained from the reference and clinical
mycobacterial strains in this study were interpreted as accurate
and specific. In each case, the positive controls yielded the
expected and identifying profiles, whereas the negative controls
yielded either no detectable peaks or faint profiles that were not
identified by the system. Moreover, the identity of both the
reference strains and the clinical isolates were validated by partial
rpoB sequencing in parallel with the MALDI-TOF MS identifi-
cation [36].
In this study, MALDI-TOF MS spectra were obtained after the
inactivation of the isolates. M. tuberculosis complex mycobacteria
are harmful organisms that have previously been found to be
responsible for cases of laboratory-acquired tuberculosis in
laboratory staff [39]. M. tuberculosis species are Biosafety Level 3
organisms that must be inactivated prior to manipulation outside a
biological safety cabinet to avoid potentially exposing the
laboratory staff to contamination [39,40]. Because the tuberculous
nature of AFB organisms cannot be determined by microscopic
observation, we suggest that systematic inactivation of AFB
organisms is warranted prior to their identification by MALDI-
TOF MS. Although some previous studies did not mention how
the mycobacteria were inactivated prior to MALDI-TOF MS
analysis [21,33], ethanol has been used for this purpose [19,41].
We noticed that the latter protocol relied on the centrifugation of
mycobacteria prior to ethanol inactivation, which carries the risk
of generating MTC mycobacteria aerosols that are potentially
harmful for the laboratory staff. We aimed to avoid any
centrifugation of non-inactivated mycobacteria and therefore
chose to inactivate the mycobacteria by heating, a procedure
previously reported to effectively inactivate mycobacteria, includ-
ing MTC mycobacteria, after 30 minutes at 95uC [18,37,42,43].
We were also concerned that the use of ethanol could interfere
with the quality of the spectra because ethanol has a protein
precipitating action. Indeed, when we used ethanol to kill
mycobacteria in liquid medium, it precipitated all the proteins in
the medium, including those of the mycobacteria. As previously
reported [21], the composition of the medium (either Middlebrook
7H9 liquid medium or solid blood-agar medium) did not interfere
with identification by mass spectrometry, especially after the
incorporation of washing steps.
In this study, the addition of Tween-20 during the inactivation
phase increased the quality of the MALDI-TOF MS spectra of
mycobacteria. Tween-20 is a detergent that disrupts the cords
formed by mycobacteria. Bruker and the authors of a later work
[18] used a micropestle for this step. However, we chose to use
Tween-20, which is easier to manipulate and more cost-effective.
Breaking the cell wall was another crucial step that facilitated the
extraction of mycobacterial proteins. Indeed, we previously
observed that disrupting the strong cell wall of mycobacteria was
necessary for their proper molecular detection [44]. This was also
the case for the molecular detection of methanogenic Archaea,
another group of prokaryotes with a strong cell wall, using either a
molecular approach [45] or MALDI-TOF MS (Dridi and
Drancourt, unpublished data). Using the protocol described here
allowed us to decrease the required inoculum of mycobacteria
down to 10
5 CFU/mL, which is the lowest inoculum reported for
the efficient identification of mycobacteria by MALDI-TOF MS.
Although the initial studies and some recent reports used a non-
calibrated inoculum [18,19,21], more recent studies incorporated
a high-concentration (10
8–10
10 CFU/mL) inoculum [33]. Ob-
taining such a high-concentration inoculum requires extensive,
time-consuming culture and exposes laboratory personnel to
potentially harmful pathogens for extended periods of time.
Over the past five years, our Mycobacteriology Reference
Laboratory, serving a cosmopolitan area with 1–2 million
inhabitants identified 354 new cases of Mycobacterium infection,
including 295 new cases of M. tuberculosis infection and 33 new
cases of MAC infections (2005 to 2009). Other non-tuberculous
mycobacteria isolated in our laboratory during this period were M.
chelonae (7 cases), M. lentiflavum (5 cases), M. fortuitum (3 cases), M.
xenopi (3 cases), M. gordonae (3 cases), M. kansasii (2 cases), M.
marinum (2 cases) and M. phocaicum (1 case). We set up a MALDI-
TOF MS database that included the Mycobacterium organisms most
frequently identified over the last several years. This local database
Table 3. Spectra obtained from Mycobacterium tuberculosis H37Rv using the tested protocols.
Protocol
Number
of peaks Mean intensity (+/2 standard deviation) of the most prevalent peaks
Identification
score average
5340 m/z 5500 m/z 5690 m/z 10670 m/z 10700 m/z 11380 m/z
(1) 82 7 0 ( +/278) 171(+/257) 139(+/245) 118(+/237) 61(+/214) 44(+/212) 1.45
(2) 8 5846(+/22797) 1804(+/21007) 2544(+/21248) 1968(+/2960) 1400(+/2594) 1518(+/2213) 1.87
(3) 11 5349(+/24850) 4037(+/23835) 4314(+/22912) 2847(+/22851) 2077(+/22115) 2557(+/22229) 2.17
(4) 11 4798(+/25400) 2531(+/22324) 1950(+/22252) 1681(+/21709) 949(+/21258) 675(+/21380) 2.43
(5) 0 2 2
(6) 0 2 2
(7) 11 0 0 7 ( +/2 260) 2
(8) 11 6166(+/22477) 2910(+/22503) 3122(+/22212) 2276(+/21580) 2435(+/21539) 2148(+/21708) 2.51
Tests were done 10 times by using inactivation protocol A.
doi:10.1371/journal.pone.0024720.t003
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contained approximately 80 Mycobacterium spectra representative of
40 Mycobacterium species (June 2010 version) (Table S1). Although
this database is enriched in Mycobacterium species most frequently
encountered in our geographical region, nevertheless it is the
largest Mycobacterium MALDI-TOF database ever published,
comprising of 62 species and 177 references to be compared with
previous reports comprising of 4–53 species and 5–53 reference
spectra [18–21]. Therefore, present database could likely serve as
an efficient tool for the identification of mycobacteria in other
geographical regions. Although the M. tuberculosis complex and M.
avium complex organisms together represented more than 90% of
Mycobacterium isolates in our laboratory, the Bruker Daltonics
database included only eight M. tuberculosis spectra and six M. avium
spectra out of a total of 40 Mycobacterium spectra. In contrast, we
previously noted that a library of $10 reference spectra was
necessary for the accurate MALDI-TOF MS identification of
cultured bacteria [25]. In this work, we therefore expanded the
Bruker Daltonics database by 37% by adding a total of 43
reference MALDI-TOF MS spectra, and we doubled the number
of MTC references and tripled those of MAC.
In this study, we evaluated the prospective use of MALDI-TOF
MS for the routine identification of mycobacteria isolates from
specimens in patients suspected of pulmonary tuberculosis. While
previous studies provided the proof-of-concept that MALDI-TOF
MS could be used for the first-line identification of mycobacteria
[18,19,21], these studies were based on the retrospective analysis
of mycobacteria retrieved from collections. The few studies
incorporating both M. tuberculosis complex isolates and non-
tuberculous mycobacteria suffered from limitations that would
prevent their application to routine laboratory use.
In conclusion, MALDI-TOF MS has been successfully adapted
for the routine identification of mycobacteria. This revolutionary
technique allows for the easier and faster diagnosis of mycobac-
terial pathogens compared with conventional phenotypic identi-
fication methods. MALDI-TOF MS therefore appears to be an
alternative first-line approach to the routine identification of the
vast majority of bacteria commonly cultured in the clinical
microbiology laboratory [25,32].
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